- Home
- HIFS vs TRML Comparison
HIFS vs TRML Comparison
Compare HIFS & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIFS
- TRML
- Stock Information
- Founded
- HIFS 1834
- TRML 2021
- Country
- HIFS United States
- TRML United States
- Employees
- HIFS N/A
- TRML N/A
- Industry
- HIFS Major Banks
- TRML Biotechnology: Pharmaceutical Preparations
- Sector
- HIFS Finance
- TRML Health Care
- Exchange
- HIFS Nasdaq
- TRML Nasdaq
- Market Cap
- HIFS 617.7M
- TRML 598.9M
- IPO Year
- HIFS N/A
- TRML N/A
- Fundamental
- Price
- HIFS $284.90
- TRML $47.70
- Analyst Decision
- HIFS
- TRML Hold
- Analyst Count
- HIFS 0
- TRML 12
- Target Price
- HIFS N/A
- TRML $47.04
- AVG Volume (30 Days)
- HIFS 48.8K
- TRML 1.7M
- Earning Date
- HIFS 10-10-2025
- TRML 11-06-2025
- Dividend Yield
- HIFS 0.89%
- TRML N/A
- EPS Growth
- HIFS 63.41
- TRML N/A
- EPS
- HIFS 15.35
- TRML N/A
- Revenue
- HIFS $75,066,000.00
- TRML N/A
- Revenue This Year
- HIFS N/A
- TRML N/A
- Revenue Next Year
- HIFS N/A
- TRML N/A
- P/E Ratio
- HIFS $18.45
- TRML N/A
- Revenue Growth
- HIFS 37.00
- TRML N/A
- 52 Week Low
- HIFS $209.71
- TRML $11.56
- 52 Week High
- HIFS $300.00
- TRML $47.75
- Technical
- Relative Strength Index (RSI)
- HIFS 58.01
- TRML 94.34
- Support Level
- HIFS $278.82
- TRML $22.31
- Resistance Level
- HIFS $289.76
- TRML $47.69
- Average True Range (ATR)
- HIFS 8.72
- TRML 0.92
- MACD
- HIFS -0.27
- TRML 1.57
- Stochastic Oscillator
- HIFS 77.12
- TRML 99.73
About HIFS Hingham Institution for Savings
Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.